Man Group PLC Regenxbio Inc. Transaction History

Man Group PLC

$54.1 Billion
Q3 2025

A detailed history of Man Group PLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Man Group PLC holds 112,398 shares of RGNX stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,398

Previous 84,799 32.55%

Holding current value

$1.29 Million

Previous $696,000 55.75%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$7.46 - $9.89 $205,888 - $272,954	27,599 Added 32.55%	112,398 $1.08 Million
Q2 2025 Aug 14, 2025	BUY	$5.31 - $10.4 $279,263 - $546,956	52,592 Added 163.29%	84,799 $696,000
Q1 2025 May 15, 2025	BUY	$5.92 - $8.7 $190,665 - $280,200	32,207 New	32,207 $230,000
Q3 2024 Nov 14, 2024	BUY	$10.49 - $14.39 $132,719 - $182,062	12,652 New	12,652 $132,000
Q3 2023 Nov 14, 2023	SELL	$16.46 - $19.99 $490,623 - $595,841	-29,807 Reduced 47.92%	32,400 $533,000

Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $635,666 - $800,947	-36,893 Reduced 37.23%	62,207 $1.24 Million
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $34,659 - $47,062	-1,917 Reduced 1.9%	99,100 $1.87 Million
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $816,346 - $989,620	40,017 Added 65.6%	101,017 $2.29 Million
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $200,610 - $315,360	9,000 Added 17.31%	61,000 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $853,335 - $1.55 Million	44,100 Added 558.23%	52,000 $1.28 Million
Q1 2022 May 16, 2022	BUY	$24.62 - $34.31 $194,498 - $271,049	7,900 New	7,900 $262,000
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $191,514 - $238,831	-5,900 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$33.61 - $49.95 $1.06 Million - $1.57 Million	-31,400 Reduced 84.18%	5,900 $201,000
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $403,395 - $750,662	15,211 Added 68.86%	37,300 $1.69 Million
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $1.53 Million - $2.28 Million	-56,754 Reduced 71.98%	22,089 $607,000
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $2.19 Million - $3.42 Million	78,843 New	78,843 $2.9 Million
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $1.3 Million - $2.08 Million	-40,794 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $552,720 - $780,256	-13,160 Reduced 24.39%	40,794 $2.1 Million
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $110,826 - $169,551	2,715 Added 5.3%	53,954 $3.09 Million
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $847,552 - $1.63 Million	21,671 Added 73.29%	51,239 $2.15 Million
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $1.61 Million - $2.04 Million	24,830 Added 524.06%	29,568 $2.23 Million
Q2 2018 Aug 14, 2018	BUY	$27.2 - $74.35 $128,873 - $352,270	4,738 New	4,738 $340,000

Others Institutions Holding RGNX

# of Institutions

189

Shares Held

44.3M

Call Options Held

138K

Put Options Held

117K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $498M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account